Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-05-15
1993-04-06
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514326, 514432, 514456, A61K 3135, A61K 3138, A61K 31435, A61K 31445
Patent
active
052004104
ABSTRACT:
A method of treating cerebral apoplexy in a patient in need thereof which comprises administering to said patient an amount effective therefor of a serotonin agonist which has a binding strength of less than 10,000 nmol/l on binding to 5HT.sub.1A receptors.
REFERENCES:
patent: 5049588 (1991-09-01), Nicholson et al.
Brain Research, vol. 435, No. 1-2, 1987, pp. 305-309.
Neurology, vol. 35, No. 4, Apr. 1985, pp. 584-487.
Bielenberg Gerhard-Wilhelm
Traber Jorg
Friedman S. J.
Troponwerke GmbH & Co.
LandOfFree
Medicaments for the treatment of cerebral apoplexy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicaments for the treatment of cerebral apoplexy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicaments for the treatment of cerebral apoplexy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-536878